Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals Nov 24, 2021 09:12AM
Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals Nov 24, 2021 09:12AM
Supernus Pharma (SUPN) Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals (ADMS) Tender Offer Nov 23, 2021 08:01AM
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer Nov 23, 2021 08:00AM
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer Nov 23, 2021 08:00AM


Oct 11, 2021 06:30AM Supernus Pharma (SUPN) Acquires Adamas Pharmaceuticals (ADMS) for $8.10/sh
Oct 11, 2021 06:30AM Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
Oct 11, 2021 06:30AM Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
Dec 5, 2012 07:07AM Lazard Capital Starts Supernus Pharmaceuticals (SUPN) at Buy